Who Paid My Doc
Ruy Carrasco
Pediatric Rheumatology Austin, TX Medical Doctor
NPI 1063478154 CMS profile 184621
5301 Davis Ln Ste 200A, Austin, TX 78749
General payments
$26,290
Research payments
$3,200
Ownership & investment interest
$0
Research they led as principal investigator
$153,478
Through program year 2025, Ruy Carrasco of Austin, TX is reported in the CMS Open Payments database as having received $26,290 across 424 general payments and $3,200 in research payments paid to them. Separately, studies naming them as principal investigator received $153,478 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 94th percentile of Pediatric Rheumatology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $8,784 | 100 | |
| 2024 | General | $1,584 | 72 | |
| 2024 | Research | $3,200 | 1 | |
| 2023 | General | $1,673 | 62 | |
| 2022 | General | $7,103 | 103 | |
| 2021 | General | $5,202 | 36 | |
| 2020 | General | $1,453 | 31 | |
| 2019 | General | $492 | 20 |
Beside peers
- Ruy Carrasco
- Pediatric Rheumatology median
- Middle half of Pediatric Rheumatology
- National median
In program year 2025, general payments to Ruy Carrasco were reported at $8,784. Among 204 Pediatric Rheumatology profiles paid that year, the median was $146 and the middle half received between $95 and $522.
Show as a table
| Year | Ruy Carrasco | Pediatric Rheumatology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $492 | $141 | $61–$1,029 | $163 |
| 2020 | $1,453 | $113 | $33–$419 | $114 |
| 2021 | $5,202 | $189 | $61–$1,640 | $132 |
| 2022 | $7,103 | $120 | $28–$404 | $149 |
| 2023 | $1,673 | $97 | $41–$222 | $160 |
| 2024 | $1,584 | $139 | $48–$606 | $164 |
| 2025 | $8,784 | $146 | $95–$522 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
425 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Rheumatology in Texas
Tiphanie Vogel
Pediatric Rheumatology · Houston, TX
Eyal Muscal
Pediatric Rheumatology · Houston, TX
Ivan Chinn
Pediatric Rheumatology · Houston, TX
Ankur Kamdar
Pediatric Rheumatology · Houston, TX
Melissa Mizesko
Pediatric Rheumatology · Corpus Christi, TX
Ricardo Guirola
Pediatric Rheumatology · Fort Worth, TX
Related records
Pediatric Rheumatology in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Rheumatology
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.